AJO LP’s Amphastar Pharmaceuticals AMPH Stock Holding History

AJO LP’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-107,182	Closed	-$2.01M	–	289
2020 Q3	$2.01M	Buy	107,182 +3,907	+4%	+$78.7K	0.02%	384
2020 Q2	$2.32M	Buy	+103,275	New	+$1.89M	0.02%	362

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AJO LP's AMPH Position: Q4 2020 in Review

AJO LP sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2020, closing a stake of 107,182 shares — an estimated $2.01M sold.

AJO LP first reported a position in AMPH in Q2 2020 and held it in 2 quarters. The position peaked at $2.32M in Q2 2020. 129 funds tracked by Wall St. Rank hold AMPH as of Q4 2020.

AJO LP reported no remaining Amphastar Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
AJO LP sold 107,182 Amphastar Pharmaceuticals shares in Q4 2020, an estimated $2.01M.
AJO LP first reported a position in Amphastar Pharmaceuticals in Q2 2020 and held it in 2 quarters.
AJO LP's Amphastar Pharmaceuticals position peaked at $2.32M in Q2 2020.
129 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2020.

Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.